Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-30 to 2023-02-02
Current total value of award: $77.7
Description: 4559768184!ARTIFICIAL TEARS SOLU